{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Sodium-Glucose Cotransporter-2 Inhibitors

Purpose of Activity

To provide information about SGLT2 inhibitors, their efficacy, and warnings about their potentially dangerous adverse reactions.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the indications for use and actions of SGLT2 inhibitors.
  2. Discuss the potential dangerous adverse reactions of SGLT2 inhibitors.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours

Test Code: NP0417B
Published: Apr 2017
Expires: 3/6/2020
Passing Score: 13/18 (72%)
Authors: Emily Ashjian, PharmD, BCPS, BCACP; Jeffrey Tingen, PharmD, MBA, BCPS, BCACP, CDE